Yiling Pharmaceutical has secured a deal with Nigeria to provide traditional Chinese medicine (TCM) exports to the country and sees a strong opportunity to partner with African herbal medicine manufacturers for new product development.
Hong Kong-based NOOCI has launched in United States first through its website and an online distribution platform and is expanding offline via its practitioner’s programme – with over 100 practitioners across the country signed up thus far.
Korea Ginseng Corp has opened a new R&D centre in a major push to establish itself as the world’s biggest herbal health company, while strategies such as diversification of product categories and formats are in motion to fuel its bold ambitions.
From authentication and identification of botanicals to approached to establishing safety and efficacy, the 21st International Conference on the Science of Botanicals (ICSB) provides stakeholders in the botanicals space a unique opportunity to learn and...
ASX-listed Australian firm McPherson’s has reported almost 90 per cent annual growth in its health business in FY22, with the herbals brand Fusion – previously owned by Blackmores’ Global Therapeutics – performing particularly well.
A new herbal formula for joint health has debuted on the market to compete with old category standbys glucosamine and chondroitin. The Indian/American company behind it says its vegan positioning and clinical backing sets it apart.
Here's a recap of our 10 most read nutrition stories in January, featuring regulatory updates from China and Australia, Nestlé's moves in the A2 milk market, the top APAC supplement trends to watch this year, and more.
We look back at our 10 most read trend stories this year, including news on the daigou phenomenon, personalised nutrition in APAC, ASEAN's bright future in nutrition, the top supplement categories and ingredients in Indonesia and Australia, and what...